FR2696744B1 - 2-Pyrrolidone derivatives, their preparation process and their therapeutic applications. - Google Patents

2-Pyrrolidone derivatives, their preparation process and their therapeutic applications.

Info

Publication number
FR2696744B1
FR2696744B1 FR9212163A FR9212163A FR2696744B1 FR 2696744 B1 FR2696744 B1 FR 2696744B1 FR 9212163 A FR9212163 A FR 9212163A FR 9212163 A FR9212163 A FR 9212163A FR 2696744 B1 FR2696744 B1 FR 2696744B1
Authority
FR
France
Prior art keywords
preparation process
therapeutic applications
pyrrolidone derivatives
pyrrolidone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9212163A
Other languages
French (fr)
Other versions
FR2696744A1 (en
Inventor
Marguerite Benharkate
Philippe Lefevre
Michel Pairet
Alain Renaud
Tri Vo Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Jacques Logeais SA
Original Assignee
Laboratoires Jacques Logeais SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Jacques Logeais SA filed Critical Laboratoires Jacques Logeais SA
Priority to FR9212163A priority Critical patent/FR2696744B1/en
Publication of FR2696744A1 publication Critical patent/FR2696744A1/en
Application granted granted Critical
Publication of FR2696744B1 publication Critical patent/FR2696744B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9212163A 1992-10-12 1992-10-12 2-Pyrrolidone derivatives, their preparation process and their therapeutic applications. Expired - Fee Related FR2696744B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9212163A FR2696744B1 (en) 1992-10-12 1992-10-12 2-Pyrrolidone derivatives, their preparation process and their therapeutic applications.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9212163A FR2696744B1 (en) 1992-10-12 1992-10-12 2-Pyrrolidone derivatives, their preparation process and their therapeutic applications.

Publications (2)

Publication Number Publication Date
FR2696744A1 FR2696744A1 (en) 1994-04-15
FR2696744B1 true FR2696744B1 (en) 1994-12-30

Family

ID=9434433

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9212163A Expired - Fee Related FR2696744B1 (en) 1992-10-12 1992-10-12 2-Pyrrolidone derivatives, their preparation process and their therapeutic applications.

Country Status (1)

Country Link
FR (1) FR2696744B1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
SE9504661D0 (en) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
DE19939756A1 (en) * 1999-08-21 2001-02-22 Merck Patent Gmbh New 1-(1-ethyl-piperidin-4-yl)-1-(phenyl or heterocyclyl)-alkanol derivatives, are 5-HT(2A) receptor antagonists useful e.g. for treating schizophrenia, depression, memory disorders or eating disorders
SE9904673D0 (en) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (en) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (en) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
AR035974A1 (en) 2001-05-18 2004-07-28 Astrazeneca Ab DERIVATIVES OF DIARILMETIL PIPERAZINA, PROCESSES FOR THEIR PREPARATION, USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEDICINES AND PHARMACEUTICAL COMPOSITION
SE0203300D0 (en) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (en) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (en) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
MX2007001240A (en) 2004-08-02 2007-03-23 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof.
FR2939309B1 (en) 2008-12-08 2010-12-17 Oreal USE OF A 2-PYRROLIDINONE 4-CARBOXY ESTER DERIVATIVE AS A SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THEM
FR2939310B1 (en) 2008-12-08 2012-04-20 Oreal COSMETIC COMPOSITIONS COMPRISING A 2-PYRROLIDINONE 4-CARBOXY ESTER DERIVATIVE AND A TRIAZINE LIPOPHILIC FILTER; USE OF SAID DERIVATIVE AS A SOLVENT OF A TRIAZINE LIPOPHILIC FILTER
FR2939315B1 (en) 2008-12-08 2011-01-21 Oreal COSMETIC COMPOSITION CONTAINING DIBENZOYLMETHANE DERIVATIVE AND ESTER COMPOUND OF 2-PYRROLIDINONE 4-CARBOXY; METHOD FOR PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE DERIVATIVE
FR2961101B1 (en) 2010-06-09 2013-01-25 Oreal COMPOSITION COMPRISING AT LEAST 2-PYRROLIDONE FUNCTIONALIZED BY RADICAL ESTER OR AMIDE, AND AT LEAST ONE DIRECT PIGMENT OR COLORANT FOR DYEING KERATINIC MATERIALS
FR2961093A1 (en) 2010-06-09 2011-12-16 Oreal COSMETIC COMPOSITION COMPRISING A POLYMER AND A 4-CARBOXY 2-PYRROLIDINONE DERIVATIVE, COSMETIC TREATMENT METHOD AND COMPOUND
FR2977153B1 (en) 2011-06-29 2013-08-02 Oreal COSMETIC COMPOSITION COMPRISING FUNCTIONALIZED OIL AND SOLVENT AND METHOD OF COSMETIC TREATMENT
WO2013010590A1 (en) 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
DE102012017739A1 (en) 2012-09-07 2014-03-13 Clariant International Ltd. Process for the preparation of N-substituted Pyrrolidoncarbonsäureestern

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1484002A (en) * 1974-11-25 1977-08-24 Richardson Merrell Inc 11-aminoalkylmorphanthridin-11-ols
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
DE3634220A1 (en) * 1986-10-08 1988-04-14 Boehringer Ingelheim Kg USE OF 1-BENZYL-AMINOALKYL-PYRROLIDINONES AS AN ANTIDEPRESSIVE
AU596499B2 (en) * 1987-01-20 1990-05-03 Dainippon Pharmaceutical Co. Ltd. Aromatic heterocyclic carboxylic acid amide derivatives, process for their preparation, and pharmaceutical composition containing same
FR2618436B1 (en) * 1987-07-23 1989-10-27 Synthelabo PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
US4835157A (en) * 1988-03-15 1989-05-30 Ortho Pharmaceutical Corporation Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents

Also Published As

Publication number Publication date
FR2696744A1 (en) 1994-04-15

Similar Documents

Publication Publication Date Title
FR2696744B1 (en) 2-Pyrrolidone derivatives, their preparation process and their therapeutic applications.
FR2696176B1 (en) Piperidine derivatives, their preparation and their therapeutic application.
DZ418A1 (en) Cephalosporin derivatives, their preparation process and their therapeutic application.
DZ1869A1 (en) New erythromycin derivatives, their preparation process and their use as medicaments.
DZ1878A1 (en) New erythromycin derivatives, their preparation process and their use as drugs.
FR2707641B1 (en) Compounds of imidazol-5-carboxamide, their process for preparing their intermediates and their use in therapy.
DZ2172A1 (en) Triazole derivatives useful in therapy, process for their preparation and compositions containing them.
FR2709754B1 (en) Compounds 2 'or 3'-deoxy- and 2', 3'-dideoxy-beta-L-pentofuranonucleosides, preparation process and therapeutic application, in particular anti-viral.
FR2702660B1 (en) Stabilized therapeutic compositions and process for their preparation.
OA06951A (en) Thienopyridinone derivatives, their preparation process and their therapeutic application.
FR2692579B1 (en) New picromycin derivatives, their preparation process and their use as medicines.
FR2707994B1 (en) Molecular composites of siloxane, process for the preparation of said composites, and their uses.
FR2718441B1 (en) New compounds of benzisoséléna-zoline and -zine structure, their preparation process and their therapeutic applications.
FR2696177B1 (en) Piperidine derivatives, their preparation and their therapeutic application.
FR2707638B1 (en) New amino acid derivatives, their preparation processes and their therapeutic application.
FR2697250B1 (en) Derivatives of beta, beta-dimethyl-4-piperidineethanol and 1,2,3,6-tetrahydro-beta, beta-dimethyl-4-pyridineethanol, their preparation process and their use in therapy.
FR2695645B1 (en) Process for the preparation of polyaminoborazines.
FR2691464B1 (en) New derivatives of 1-oxa 6-azacyclopentadecane 13,15-dione, their preparation process and their use as medicaments.
FR2693197B1 (en) New quinoline derivatives, their preparation process and their therapeutic application.
OA06504A (en) Benzothiazole derivatives, their preparation process and their therapeutic applications.
FR2699919B1 (en) Imidazole derivatives, their preparation process and their therapeutic application.
FR2703354B1 (en) DERIVATIVES OF 1, 2, 5, 6-TETRAHYDROPYRIDINE, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATIONS.
FR2697253B1 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use.
OA09903A (en) Benzofuranylimidazol derivatives, their preparation process and a therapeutic composition containing them.
FR2719047B1 (en) New benzylamine derivatives, their manufacturing process and the pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
ST Notification of lapse